Products for Research Use Only
RegisterLogin

Canertinib (CI-1033)

CAT: 0957-S1019-50mgSize: 50 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0957-S1019-50mgSize:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
267243-28-7
Synonyms
PD183805
Target
EGFR
Applications
Protein Tyrosine Kinase
Smiles
C=CC (=O) NC1=C (C=C2C (=C1) C (=NC=N2) NC3=CC (=C (C=C3) F) Cl) OCCCN4CCOCC4
Molecular Formula
C24H25ClFN5O3
Additionnal Information
Canertinib (CI-1033, PD183805) is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4. Phase 3.
Storage Conditions
2 years -80 in solvent

Related Products

CatalogName
S0711-25mgCanertinib dihydrochloride
S0711-1gCanertinib dihydrochloride
S0711-100mgCanertinib dihydrochloride
S0711-5mgCanertinib dihydrochloride
S0711-01Canertinib dihydrochloride
F2820-01Apolipoprotein CI/Apo-CI Antibody [N16B24]
S1020-10mM/1mLPD184352 (CI-1040)
S1020-1gPD184352 (CI-1040)
S1020-01PD184352 (CI-1040)
S1020-5mgPD184352 (CI-1040)

Alternative Products

CatalogName
MBS384507-01Canertinib (CI-1033)
MBS130584-01Canertinib, CI 1033
MBS8506167-01CI-1033 (Canertinib)
A10211-5Canertinib (CI-1033) 5mg
A10211-100Canertinib (CI-1033) 100mg
A10211-25Canertinib (CI-1033) 25mg
1617-5Canertinib (CI-1033, PD-183805)
SM-101070-50Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%)
C1075-25Canertinib, Dihydrochloride (N-[4-[ (3-Chloro-4-fluorophenyl) amino]-7-[3- (4-morpholinyl) propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride, CI-1033, PD183805)
MBS655332-01Canertinib, Dihydrochloride (N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride, CI-1033, PD183805)

Popular Products